- Home
- GDOT vs ORIC Comparison
GDOT vs ORIC Comparison
Compare GDOT & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDOT
- ORIC
- Stock Information
- Founded
- GDOT 1999
- ORIC 2014
- Country
- GDOT United States
- ORIC United States
- Employees
- GDOT N/A
- ORIC N/A
- Industry
- GDOT Finance: Consumer Services
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- GDOT Finance
- ORIC Health Care
- Exchange
- GDOT Nasdaq
- ORIC Nasdaq
- Market Cap
- GDOT 577.7M
- ORIC 633.7M
- IPO Year
- GDOT 2010
- ORIC 2020
- Fundamental
- Price
- GDOT $10.78
- ORIC $8.21
- Analyst Decision
- GDOT Hold
- ORIC Strong Buy
- Analyst Count
- GDOT 4
- ORIC 9
- Target Price
- GDOT $10.75
- ORIC $18.75
- AVG Volume (30 Days)
- GDOT 574.6K
- ORIC 331.7K
- Earning Date
- GDOT 11-07-2024
- ORIC 11-12-2024
- Dividend Yield
- GDOT N/A
- ORIC N/A
- EPS Growth
- GDOT N/A
- ORIC N/A
- EPS
- GDOT N/A
- ORIC N/A
- Revenue
- GDOT $1,629,683,000.00
- ORIC N/A
- Revenue This Year
- GDOT N/A
- ORIC N/A
- Revenue Next Year
- GDOT $10.91
- ORIC N/A
- P/E Ratio
- GDOT N/A
- ORIC N/A
- Revenue Growth
- GDOT 10.45
- ORIC N/A
- 52 Week Low
- GDOT $7.70
- ORIC $6.33
- 52 Week High
- GDOT $13.58
- ORIC $16.65
- Technical
- Relative Strength Index (RSI)
- GDOT 48.01
- ORIC 40.22
- Support Level
- GDOT $10.54
- ORIC $7.41
- Resistance Level
- GDOT $11.44
- ORIC $8.42
- Average True Range (ATR)
- GDOT 0.45
- ORIC 0.56
- MACD
- GDOT 0.04
- ORIC -0.16
- Stochastic Oscillator
- GDOT 42.69
- ORIC 28.57
About GDOT Green Dot Corporation $0.001 par value
Green Dot Corp is a financial technology company that provides financial services for consumers in the United States without good banking options. It has three segments Consumer Services, Business to Business Services(B2B), and Money Movement Services. The company generates maximum revenue from B2B segment. Its B2B Services segment consists of revenues and expenses derived from (i) its partnerships with prominent consumer and technology companies that make banking products and services available to their consumers, partners and workforce through integration with its banking platform (the "Banking-as-a-Service", or "BaaS channel"), and (ii) a comprehensive payroll platform that it offers to corporate enterprises (the "Employer channel") to facilitate payments for today's workforce.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.